Home Hatchtech inks $279m head lice deal as VC market comes to life
 

Keywords :   


Hatchtech inks $279m head lice deal as VC market comes to life

2015-09-13 13:56:17| Biotech - Topix.net

Australian pharmaceutical company Hatchtech has inked a deal worth up to $279 million with Indian giant Dr. Reddy's for the commercialisation of its innovative head lice treatment. Dr Reddy's Laboratories, a $US10.3 billion integrated pharmaceutical group listed in New York, will pay Hatchtech an undisclosed upfront fee, up to $85 million in pre-commercialisation milestone payments, and the remainder of the $279 million subject to sales-based milestones.

Tags: to life market head

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
24.11STEINBACH40
24.11 Sepua Crue F-170
24.11 SECRET
24.11CRAwith
24.1111/15)&&
24.11 8
24.11
24.11F2023 23
More »